Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of FTO Gene Variation on Body Composition, Lipid Profile, Insulin Resistance, Advanced Glycation End-Products and Ghrelin Levels in Response to Hypocaloric, Protein Rich-Diet

NCT06426017 is registered in ClinicalTrials.gov with Khyber Medical University Peshawar as lead sponsor.

NCT NCT06426017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06426017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of FTO Gene Variation on Body Composition, Lipid Profile, Insulin Resistance, Advanced Glycation End-Products and Ghrelin Levels in Response to Hypocaloric, Protein Rich-Diet
Lead sponsor
Khyber Medical University Peshawar
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2024
Completion date
August 25, 2024
Enrollment
110 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advance glycation, dyslipidemias, inflammation, insulin resistance, obesity